http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201070012-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EA-201070012-A1 |
titleOfInvention | METABOLITES for (R) -3- (4- (7H-PYRROLO [2,3-d] PYRIMIDIN-4-IL) -1H-Pyrazol-1-IL) -3-CYCLOPENTYL-PROPHANITRIL, JANUS KINAZ INHIBITOR |
abstract | This invention provides active metabolites of 3- (4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-cyclopentylpropanenitrile, which modulate the activity of Janus kinases and which are used for treatment of diseases associated with the activity of Janus kinases, including, for example, diseases associated with the immune system, skin diseases, myeloid proliferative disorders, cancer and other diseases. |
priorityDate | 2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.